3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
7
Triple Negative Breast Neoplasms
5
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasm Metastasis
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Melanoma, Cutaneous Malignant
1
Head and Neck Neoplasms
1
GastroEsophageal Cancer
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Pancreatic Ductal
1
CLDN18.2 Positive
1
Anal Cancer Metastatic
1
Adenocarcinoma
1
Interventions
Specimen Handling
6
Cytarabine
6
fludarabine
5
Biopsy
5
fludarabine phosphate
4
Whole-Body Irradiation
4
Tacrolimus
4
Granulocyte Colony-Stimulating Factor
4
Cyclophosphamide
4
venetoclax
3
decitabine and cedazuridine drug combination
3
Mycophenolic Acid
3
Melphalan
3
Injections
3
Idarubicin
3
CPX-351
3
Busulfan
3
Blood Specimen Collection
3
ruxolitinib
2
nilotinib
2
luspatercept
2
ivosidenib
2
asciminib
2
Thiotepa
2
Sirolimus
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Liposomes
2
Gemtuzumab
2
Filgrastim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Albumin-Bound Paclitaxel
×
30 days
×
Clear all
No trials found.